Revisão Acesso aberto Revisado por pares

Adenovirus: The First Effective In Vivo Gene Delivery Vector

2014; Mary Ann Liebert, Inc.; Volume: 25; Issue: 1 Linguagem: Inglês

10.1089/hum.2013.2527

ISSN

1557-7422

Autores

Ronald G. Crystal,

Tópico(s)

CRISPR and Genetic Engineering

Resumo

Human Gene TherapyVol. 25, No. 1 Pioneer PerspectiveAdenovirus: The First Effective In Vivo Gene Delivery VectorRonald G. CrystalRonald G. CrystalPublished Online:20 Jan 2014https://doi.org/10.1089/hum.2013.2527AboutSectionsView articleView Full TextSupplemental MaterialPDF/EPUBView Supplemental Data ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetailsCited ByAdenoviral delivery of soluble ovine OX40L or CD70 costimulatory molecules improves adaptive immune responses to a model antigen in sheep23 September 2022 | Frontiers in Cellular and Infection Microbiology, Vol. 12Preclinical model for phenotypic correction of Recessive Dystrophic Epidermolysis Bullosa by in vivo CRISPR / Cas9 delivery using adenoviral vectors.Molecular Therapy - Methods & Clinical DevelopmentCurrent clinical landscape of oncolytic viruses as novel cancer immunotherapeutic and recent preclinical advancements25 August 2022 | Frontiers in Immunology, Vol. 13BMP Gene‐Immobilization to Dental Implants Enhances Bone Regeneration25 June 2022 | Advanced Materials Interfaces, Vol. 9, No. 22Gene Therapy for Cardiac Transplantation13 July 2022Gene Therapy: Will the Promise of Optimizing Lung Allografts Become Reality?1 July 2022 | Frontiers in Immunology, Vol. 13No Genus-Specific Gene Is Essential for the Replication of Fowl Adenovirus 4 in Chicken LMH CellsMicrobiology Spectrum, Vol. 10, No. 3Role of Adenoviruses in Cancer Therapy9 June 2022 | Frontiers in Oncology, Vol. 12Hematopoietic Stem Cell Gene-Addition/Editing Therapy in Sickle Cell Disease4 June 2022 | Cells, Vol. 11, No. 11Nestin promotes pulmonary fibrosis via facilitating recycling of TGF-β receptor I8 October 2021 | European Respiratory Journal, Vol. 59, No. 5Recent Advances in the Therapeutic Strategies of Glioblastoma MultiformeNeuroscience, Vol. 491Gene therapy in neuromuscular disorders1 May 2022 | Arquivos de Neuro-Psiquiatria, Vol. 80, No. 5 suppl 1Gene therapy: Comprehensive overview and therapeutic applicationsLife Sciences, Vol. 294Restriction-Assembly: A Solution to Construct Novel Adenovirus Vector6 March 2022 | Viruses, Vol. 14, No. 3Avances en terapia génica en humanos: algunos conceptos básicos y un recorrido históricoRevista Médica Clínica Las Condes, Vol. 33, No. 2Adenoviral Transduction of Dickkopf-1 Alleviates Silica-Induced Silicosis Development in Lungs of Mice Qian Cai, Jia Ma, Jing Wang, Juying Wang, Jieda Cui, Shuang Wu, Zhaojun Wang, Na Wang, Jiaqi Wang, Dandan Yang, Jiali Yang, Jing Xue, Feng Li, Juan Chen, and Xiaoming Liu14 February 2022 | Human Gene Therapy, Vol. 33, No. 3-4Delivery of CRISPR-Cas tools for in vivo genome editing therapy: Trends and challengesJournal of Controlled Release, Vol. 342COVID-19 Vaccines: Adenoviral VectorsAnnual Review of Medicine, Vol. 73, No. 1Gene Therapy for Acute Respiratory Distress Syndrome17 January 2022 | Frontiers in Physiology, Vol. 12Recombinant Adenoviruses for Delivery of Therapeutics Following Spinal Cord Injury10 January 2022 | Frontiers in Pharmacology, Vol. 12Study of the Therapeutic Efficiency of Transduced Olfactory Ensheathing Cells in Spinal Cord Cysts Olga V. Stepanova, Anastasia D. Voronova, Anastasiia O. Sosnovtseva, Aleksei A. Stepanenko, Andrey V. Chadin, Ekaterina K. Karsuntseva, Grigorii A. Fursa, Marat P. Valikhov, Alevtina S. Semkina, Pavel O. Vorobyev, Igor V. Reshetov, and Vladimir P. Chekhonin13 January 2022 | Stem Cells and Development, Vol. 31, No. 1-2Engineering surface amphiphilicity of polymer nanostructuresProgress in Polymer Science, Vol. 124Viral vector‐based gene therapies in the clinic20 October 2021 | Bioengineering & Translational Medicine, Vol. 7, No. 1Ocular Gene Therapies23 April 2022Generation of Adenovirus for In Vitro and In Vivo Studies of Hepatocytes25 February 2022Viral vector platforms within the gene therapy landscape8 February 2021 | Signal Transduction and Targeted Therapy, Vol. 6, No. 1Spatiotemporal control of CRISPR/Cas9 gene editing20 June 2021 | Signal Transduction and Targeted Therapy, Vol. 6, No. 1Virus against virus: strategies for using adenovirus vectors in the treatment of HPV-induced cervical cancer25 February 2021 | Acta Pharmacologica Sinica, Vol. 42, No. 12Animal Models in Human Adenovirus Research1 December 2021 | Biology, Vol. 10, No. 12Functional tissue-engineered bone-like graft made of a fibrin scaffold and TG2 gene-modified EMSCs for bone defect repair26 March 2021 | NPG Asia Materials, Vol. 13, No. 1A one-step construction of adenovirus (OSCA) system using the Gibson DNA Assembly technologyMolecular Therapy - Oncolytics, Vol. 23Eukaryotic expression system complemented with expressivity of Semliki Forest Virus's RdRp and invasiveness of engineered Salmonella demonstrate promising potential for bacteria mediated gene therapyBiomaterials, Vol. 279Immunological Study of Reconstructed Common Ancestral Sequence of Adenovirus Hexon Protein27 October 2021 | Frontiers in Microbiology, Vol. 12Gene therapy for bone healing: lessons learned and new approachesTranslational Research, Vol. 236Engineering Gene Therapy: Advances and Barriers20 June 2021 | Advanced Therapeutics, Vol. 4, No. 9A guide to the optogenetic regulation of endogenous molecules26 August 2021 | Nature Methods, Vol. 18, No. 9Innovative dual system approach for selective eradication of cancer cells using viral-based delivery of natural bacterial toxin–antitoxin system25 June 2021 | Oncogene, Vol. 40, No. 31Novel Technologies for Target Delivery of Therapeutics to the Placenta during Pregnancy: A Review17 August 2021 | Genes, Vol. 12, No. 8MiRNAs and Cancer: Key Link in Diagnosis and Therapy23 August 2021 | Genes, Vol. 12, No. 8Antigen Presentation of mRNA-Based and Virus-Vectored SARS-CoV-2 Vaccines3 August 2021 | Vaccines, Vol. 9, No. 8Reasons for success and lessons learnt from nanoscale vaccines against COVID-1911 August 2021 | Nature Nanotechnology, Vol. 16, No. 8COVID-19: Myths and Reality8 July 2021 | Biochemistry (Moscow), Vol. 86, No. 7Understanding Post Entry Sorting of Adenovirus Capsids; A Chance to Change Vaccine Vector Properties24 June 2021 | Viruses, Vol. 13, No. 7Fiber modifications enable fowl adenovirus 4 vectors to transduce human cells11 June 2021 | The Journal of Gene Medicine, Vol. 84Advanced genetic engineering to achieve in vivo targeting of adenovirus utilizing camelid single domain antibodyJournal of Controlled Release, Vol. 334A Confocal Microscopic Study of Gene Transfer into the Mesencephalic Tegmentum of Juvenile Chum Salmon, Oncorhynchus keta, Using Mouse Adeno-Associated Viral Vectors26 May 2021 | International Journal of Molecular Sciences, Vol. 22, No. 11Review of candidate vaccines for the prevention of Lassa fever15 May 2021 | Problems of Virology, Vol. 66, No. 2Understanding and addressing barriers to successful adenovirus-based virotherapy for ovarian cancer19 September 2020 | Cancer Gene Therapy, Vol. 28, No. 5New Insights into the Therapeutic Applications of CRISPR/Cas9 Genome Editing in Breast Cancer12 May 2021 | Genes, Vol. 12, No. 5Nonviral Locally Injected Magnetic Vectors for In Vivo Gene Delivery: A Review of Studies on Magnetofection22 April 2021 | Nanomaterials, Vol. 11, No. 5Targeting Nestin+ hepatic stellate cells ameliorates liver fibrosis by facilitating TβRI degradationJournal of Hepatology, Vol. 74, No. 5Asprosin-neutralizing antibodies as a treatment for metabolic syndrome27 April 2021 | eLife, Vol. 10Developmental Landscape of Potential Vaccine Candidates Based on Viral Vector for Prophylaxis of COVID-1915 April 2021 | Frontiers in Molecular Biosciences, Vol. 8Systemic overexpression of interleukin-22 induces the negative immune-regulator SOCS3 and potently reduces experimental arthritis in mice16 November 2020 | Rheumatology, Vol. 60, No. 4Nonreplicating Adenoviral Vectors: Improving Tropism and Delivery of Cancer Gene Therapy14 April 2021 | Cancers, Vol. 13, No. 8Knockdown of RRM1 with Adenoviral shRNA Vectors to Inhibit Tumor Cell Viability and Increase Chemotherapeutic Sensitivity to Gemcitabine in Bladder Cancer Cells15 April 2021 | International Journal of Molecular Sciences, Vol. 22, No. 8Evolutionary Timeline of Genetic Delivery and Gene TherapyCurrent Gene Therapy, Vol. 21, No. 2VLP‐factory™ and ADDomer © : Self‐assembling Virus‐Like Particle (VLP) Technologies for Multiple Protein and Peptide Epitope Display17 March 2021 | Current Protocols, Vol. 1, No. 3Optimization of adenoviral gene transfer in human pluripotent stem cellsBiochemical and Biophysical Research Communications, Vol. 541Leptin gene-targeted editing in ob/ob mouse adipose tissue based on the CRISPR/Cas9 systemJournal of Genetics and Genomics, Vol. 48, No. 2Ocular Gene Therapies16 July 2021Rewriting CFTR to cure cystic fibrosisOcular Inflammation and Treatment Emergent Adverse Events in Retinal Gene Therapy6 July 2021 | International Ophthalmology Clinics, Vol. 61, No. 3Labeling of Mesencephalic Tegmental Neurons in a Juvenile Pacific Chum Salmon Oncorhynchus keta with Mouse Hippocampal Adeno-Associated Viral Vectors16 February 2021 | Journal of Evolutionary Biochemistry and Physiology, Vol. 57, No. 1Platforms Exploited for SARS-CoV-2 Vaccine Development25 December 2020 | Vaccines, Vol. 9, No. 1Gene Therapy and Gene Editing for Cancer TherapeuticsGene-modified leucoconcentrate for personalized ex vivo gene therapy in a mini pig model of moderate spinal cord injuryNeural Regeneration Research, Vol. 16, No. 2Overexpression of PGC-1α influences the mitochondrial unfolded protein response (mtUPR) induced by MPP+ in human SH-SY5Y neuroblastoma cells26 June 2020 | Scientific Reports, Vol. 10, No. 1Development and Applications of Viral Vectored Vaccines to Combat Zoonotic and Emerging Public Health Threats13 November 2020 | Vaccines, Vol. 8, No. 4Helper virus-free gutless adenovirus (HF-GLAd): a new platform for gene therapyBMB Reports, Vol. 53, No. 11Materials promoting viral gene delivery1 January 2020 | Biomaterials Science, Vol. 8, No. 22Immunoinformatic construction of an adenovirus-based modular vaccine platform and its application in the design of a SARS-CoV-2 vaccineInfection, Genetics and Evolution, Vol. 85Advances in Alpha-1 Antitrypsin Gene TherapyAmerican Journal of Respiratory Cell and Molecular Biology, Vol. 63, No. 5High-Throughput Cloning and Characterization of Emerging Adenovirus Types 70, 73, 74, and 752 September 2020 | International Journal of Molecular Sciences, Vol. 21, No. 17Protocol for In Vivo Evaluation and Use of Destabilizing Domains in the Eye, Liver, and BeyondSTAR Protocols, Vol. 1, No. 2Placenta-targeted treatment strategies: An opportunity to impact fetal development and improve offspring health later in lifePharmacological Research, Vol. 157Activation of OX40 and CD27 Costimulatory Signalling in Sheep through Recombinant Ovine Ligands22 June 2020 | Vaccines, Vol. 8, No. 2Novel cyclic peptides facilitating transcellular blood-brain barrier transport of macromolecules in vitro and in vivoJournal of Controlled Release, Vol. 321High-Capacity Adenoviral Vectors: Expanding the Scope of Gene Therapy21 May 2020 | International Journal of Molecular Sciences, Vol. 21, No. 10Amphiphilic Polyphenylene Dendron Conjugates for Surface Remodeling of Adenovirus 5Angewandte Chemie, Vol. 132, No. 14Amphiphilic Polyphenylene Dendron Conjugates for Surface Remodeling of Adenovirus 5Angewandte Chemie International Edition, Vol. 59, No. 14Immune Responses to Viral Gene Therapy VectorsMolecular Therapy, Vol. 28, No. 3A Triple-Regulated Oncolytic Adenovirus Carrying MicroRNA-143 Exhibits Potent Antitumor Efficacy in Colorectal CancerMolecular Therapy - Oncolytics, Vol. 16Suicide Gene Therapy for the Treatment of High-Grade Glioma: Past Lessons, Present Trends and Future Prospects6 February 2020 | Neuro-Oncology AdvancesHitching a Ride: Enhancing Nucleic Acid Delivery into Target Cells Through Nanoparticles11 January 2020Site-directed modification of adenoviral vector with combined DNA assembly and restriction-ligation cloningJournal of Biotechnology, Vol. 307Journal of Drug Targeting, Vol. 28, No. 2 A Study of Antidepressant Effect and Mechanism on Intranasal Delivery of BDNF-HA2TAT/AAV to Rats with Post-Stroke Depression 1 March 2020 | Neuropsychiatric Disease and Treatment, Vol. Volume 16Biomimetic Materials and Their Utility in Modeling the 3-Dimensional Neural EnvironmentiScience, Vol. 23, No. 1HER3-targeted protein chimera forms endosomolytic capsomeres and self-assembles into stealth nucleocapsids for systemic tumor homing of RNA interference in vivo16 October 2019 | Nucleic Acids Research, Vol. 47, No. 21Adenovirus vectors in hematopoietic stem cell genome editing20 November 2019 | FEBS Letters, Vol. 593, No. 24State‐of‐the‐art human adenovirus vectorology for therapeutic approaches9 December 2019 | FEBS Letters, Vol. 593, No. 24Efficient gene transfer into T lymphocytes by fiber-modified human adenovirus 524 April 2019 | BMC Biotechnology, Vol. 19, No. 1Danio Rerio as Model Organism for Adenoviral Vector Evaluation17 December 2019 | Genes, Vol. 10, No. 12Development of an RNA Virus-Based Episomal Vector Capable of Switching Transgene Expression6 November 2019 | Frontiers in Microbiology, Vol. 10Synthetic self-assembling ADDomer platform for highly efficient vaccination by genetically encoded multiepitope displayScience Advances, Vol. 5, No. 9Perspective on Adenoviruses: Epidemiology, Pathogenicity, and Gene Therapy19 August 2019 | Biomedicines, Vol. 7, No. 3TRIM21—From Intracellular Immunity to Therapy28 August 2019 | Frontiers in Immunology, Vol. 10Patchy Amphiphilic Dendrimers Bind Adenovirus and Control Its Host Interactions and in Vivo Distribution19 July 2019 | ACS Nano, Vol. 13, No. 8New Insights to Adenovirus-Directed Innate Immunity in Respiratory Epithelial Cells25 July 2019 | Microorganisms, Vol. 7, No. 8Magnetofection of Green Fluorescent Protein Encoding DNA-Bearing Polyethyleneimine-Coated Superparamagnetic Iron Oxide Nanoparticles to Human Breast Cancer Cells18 July 2019 | ACS Omega, Vol. 4, No. 7Adenovirus 5 recovery using nanofiber ion‐exchange adsorbents28 March 2019 | Biotechnology and Bioengineering, Vol. 116, No. 7A review of 65 years of human adenovirus seroprevalence27 May 2019 | Expert Review of Vaccines, Vol. 18, No. 6Single Plasmid-Based, Upgradable, and Backward-Compatible Adenoviral Vector Systems Hongyan Liu, Zhuozhuang Lu, Xin Zhang, Xiaojuan Guo, Lingling Mei, Xiaohui Zou, Yuxu Zhong, Min Wang, and Tao Hung12 June 2019 | Human Gene Therapy, Vol. 30, No. 6Construction, expression and antiviral activity analysis of recombinant adenovirus expressing human IFITM3 in vitroInternational Journal of Biological Macromolecules, Vol. 131Adenovirus-Mediated ABCC6 Gene Therapy for Heritable Ectopic Mineralization DisordersJournal of Investigative Dermatology, Vol. 139, No. 6Gene Therapy Leaves a Vicious Cycle24 April 2019 | Frontiers in Oncology, Vol. 9Distinct Roles of Direct Transduction Versus Exposure to the Tumor Secretome on Murine Endothelial Cells After Melanoma Gene Therapy with Interferon-β and p19Arf Igor de Luna Vieira, Rodrigo Esaki Tamura, Aline Hunger, and Bryan E. Strauss4 April 2019 | Journal of Interferon & Cytokine Research, Vol. 39, No. 4Targeted Gene Delivery through the Respiratory System: Rationale for Intratracheal Gene Transfer15 February 2019 | Journal of Cardiovascular Development and Disease, Vol. 6, No. 1Biomaterial-guided delivery of gene vectors for targeted articular cartilage repair4 December 2018 | Nature Reviews Rheumatology, Vol. 15, No. 1Disorders of the Human Circulatory SystemGeneration of infectious clone of bovine adenovirus type I expressing a visible marker geneJournal of Virological Methods, Vol. 261Widespread airway distribution and short-term phenotypic correction of cystic fibrosis pigs following aerosol delivery of piggyBac/adenovirus27 August 2018 | Nucleic Acids Research, Vol. 46, No. 18Collusion between neutralizing antibodies and other immune factions in the destruction of adenoviral vectors19 September 2018 | Proceedings of the National Academy of Sciences, Vol. 115, No. 41TRIM21 mediates antibody inhibition of adenovirus-based gene delivery and vaccination12 September 2018 | Proceedings of the National Academy of Sciences, Vol. 115, No. 41In vivo methods for acute modulation of gene expression in the central nervous systemProgress in Neurobiology, Vol. 168One-Vector System for Multiplexed CRISPR/Cas9 against Hepatitis B Virus cccDNA Utilizing High-Capacity Adenoviral VectorsMolecular Therapy - Nucleic Acids, Vol. 12Identification and characterisation of the CD40-ligand of Sigmodon hispidus27 July 2018 | PLOS ONE, Vol. 13, No. 7Construction and Characterization of Adenovirus Vectors Encoding Aspartate- β -Hydroxylase to Preliminary Application in Immunotherapy of Hepatocellular CarcinomaJournal of Immunology Research, Vol. 2018Physiological Perspective on Therapies of Lymphatic Vessels Witold W. Kilarski1 July 2018 | Advances in Wound Care, Vol. 7, No. 7Seamless assembly of recombinant adenoviral genomes from high-copy plasmids27 June 2018 | PLOS ONE, Vol. 13, No. 6Novel Vector Construction Based on Alternative Adenovirus Types via Homologous Recombination Wenli Zhang, Jun Fu, and Anja Ehrhardt1 June 2018 | Human Gene Therapy Methods, Vol. 29, No. 3Targeted in vivo knock-in of human alpha-1-antitrypsin cDNA using adenoviral delivery of CRISPR/Cas927 March 2018 | Gene Therapy, Vol. 25, No. 2Lancet Commission: Stem cells and regenerative medicineThe Lancet, Vol. 391, No. 10123The Role of Natural-Based Biomaterials in Advanced Therapies for Autoimmune Diseases25 October 2018Gene Therapy: Use of Viruses as VectorsIntegration of Multi-omics Data from Mouse Diversity Panel Highlights Mitochondrial Dysfunction in Non-alcoholic Fatty Liver DiseaseCell Systems, Vol. 6, No. 1Adaptation of vectors and drug-inducible systems for controlled expression of transgenes in the tumor microenvironmentJournal of Controlled Release, Vol. 268Reconstitution of HuR-Inhibited CUGBP1 Expression Protects Cardiomyocytes from Acute Myocardial Infarction-Induced Injury Lei Gu, Huiwen Wang, Jun Wang, Yuting Guo, Yinglong Tang, Yang Mao, Lijuan Chen, Hua Lou, and Guangju Ji10 November 2017 | Antioxidants & Redox Signaling, Vol. 27, No. 14Recent Advances in Preclinical Developments Using Adenovirus Hybrid Vectors Eric Ehrke-Schulz, Wenli Zhang, Jian Gao, and Anja Ehrhardt1 October 2017 | Human Gene Therapy, Vol. 28, No. 10Getting genetic access to natural adenovirus genomes to explore vector diversity15 July 2017 | Virus Genes, Vol. 53, No. 5Fiber-modified hexon-chimeric oncolytic adenovirus targeting cancer associated fibroblasts inhibits tumor growth in gastric carcinoma16 August 2017 | Oncotarget, Vol. 8, No. 44Identification of Excipients for Stabilizing Fiberless Adenovirus as BiopharmaceuticalsJournal of Pharmaceutical Sciences, Vol. 106, No. 7Magnetic Nanomaterials for Therapy23 June 2017Polymeric Vectors for Strategic Delivery of Nucleic Acids13 June 2017 | Nano LIFE, Vol. 07, No. 02Adenovirus-mediated gene delivery: Potential applications for gene and cell-based therapies in the new era of personalized medicineGenes & Diseases, Vol. 4, No. 2An Engineered Virus Library as a Resource for the Spectrum-wide Exploration of Virus and Vector DiversityCell Reports, Vol. 19, No. 8Viral component of the human genome9 May 2017 | Molecular Biology, Vol. 51, No. 2In situ reprogramming to transdifferentiate fibroblasts into cardiomyocytes using adenoviral vectors: Implications for clinical myocardial regenerationThe Journal of Thoracic and Cardiovascular Surgery, Vol. 153, No. 2Cardiac cellular reprogramming with transient expression vectors: Less is moreThe Journal of Thoracic and Cardiovascular Surgery, Vol. 153, No. 2Genetic Modification of the Lung Directed Toward Treatment of Human Disease Dolan Sondhi, Katie M. Stiles, Bishnu P. De, and Ronald G. Crystal1 January 2017 | Human Gene Therapy, Vol. 28, No. 1Viral Vectors, Engineered Cells and the CRISPR Revolution13 November 2017Introduction to Gene and Stem-Cell TherapyJournal of Orthopaedic Science, Vol. 22, No. 1Targeting Motor End Plates for Delivery of Adenoviruses: An Approach to Maximize Uptake and Transduction of Spinal Cord Motor Neurons13 September 2016 | Scientific Reports, Vol. 6, No. 1Adenoviral vectors encoding CRISPR/Cas9 multiplexes rescue dystrophin synthesis in unselected populations of DMD muscle cells15 November 2016 | Scientific Reports, Vol. 6, No. 1Emerging Considerations in Virus-Based Gene Transfer Systems25 October 2016Engineering Permissive Insertion Sites in the Bacteriophage Phi29 DNA-Linked Terminal Protein25 October 2016 | PLOS ONE, Vol. 11, No. 10Application of conditionally replicating adenoviruses in tumor early diagnosis technology, gene-radiation therapy and chemotherapy24 August 2016 | Applied Microbiology and Biotechnology, Vol. 100, No. 19Delivery of drugs and macromolecules to the mitochondria for cancer therapyJournal of Controlled Release, Vol. 240Influence of cell physiological state on gene delivery to T lymphocytes by chimeric adenovirus Ad5F3514 March 2016 | Scientific Reports, Vol. 6, No. 1Endosomophagy clears disrupted early endosomes but not virus particles during virus entry into cells 7 August 2016 | MattersAdenovirus vector infection of non-small-cell lung cancer cells is a trigger for multi-drug resistance mediated by P-glycoproteinBiochemical and Biophysical Research Communications, Vol. 476, No. 4Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung DiseaseAnnals of the American Thoracic Society, Vol. 13, No. Supplement_4Anti-Inflammatory Effects of Modified Adenoviral Vectors for Gene Therapy: A View through Animal Models Tested31 May 2016 | Immunological Investigations, Vol. 45, No. 5Current advances in developing cationic lipid-based nanoparticles as a vehicle for improving adenoviral gene delivery18 May 2016 | Journal of Pharmaceutical Investigation, Vol. 46, No. 4The transgenic animal platform for biopharmaceutical production28 January 2016 | Transgenic Research, Vol. 25, No. 3Interleukin-12-expressing oncolytic virus: A promising strategy for cancer immunotherapyJournal of Taibah University Medical Sciences, Vol. 11, No. 3In Vivo Hepatic Reprogramming of Myofibroblasts with AAV Vectors as a Therapeutic Strategy for Liver FibrosisCell Stem Cell, Vol. 18, No. 6Viruses, Artificial Viruses and Virus‐Based Structures for Biomedical Applications27 April 2016 | Advanced Healthcare Materials, Vol. 5, No. 12CRISPR /Cas9‐mediated somatic correction of a novel coagulator factor IX gene mutation ameliorates hemophilia in mouse10 March 2016 | EMBO Molecular Medicine, Vol. 8, No. 5Intranasal Delivery of Recombinant AAV Containing BDNF Fused with HA2TAT: a Potential Promising Therapy Strategy for Major Depressive Disorder3 March 2016 | Scientific Reports, Vol. 6, No. 1Angiogenic gene therapy for refractory angina14 December 2015 | Expert Opinion on Biological Therapy, Vol. 16, No. 3Perinatal Gene Therapy3 May 2016Adenovirus-Based Vaccines for the Treatment of Substance Use Disorders19 December 2015Recent Progress in Strategies for Adenovirus Mediated Therapeutic Cell Targeting13 April 2016Transient Expression of Functional Glucocerebrosidase for Treatment of Gaucher’s Disease in the Goat Mammary Gland20 November 2015 | Molecular Biotechnology, Vol. 58, No. 1Engineering Chimeric AdenovirusesRegulation of Adenoviral Vector-Based TherapiesFlexible DNA junction assisted efficient construction of stable gene nanoparticles for gene delivery1 January 2016 | Chemical Communications, Vol. 52, No. 9Virotherapy: cancer gene therapy at last?30 August 2016 | F1000Research, Vol. 5Immunotherapy, Vol. 8, No. 2Linear correlation between average fluorescence intensity of green fluorescent protein and the multiplicity of infection of recombinant adenovirus14 May 2015 | Journal of Biomedical Science, Vol. 22, No. 1Artificial microRNAs against the viral E6 protein provoke apoptosis in HPV positive cancer cellsBiochemical and Biophysical Research Communications, Vol. 465, No. 4Adenovirus-Vectored Broadly Neutralizing Antibodies Directed Against gp120 Prevent Human Immunodeficiency Virus Type 1 Acquisition in Humanized Mice Shan Liu, Andrew Jackson, Jagadish Beloor, Priti Kumar, and Richard E. Sutton7 May 2015 | Human Gene Therapy, Vol. 26, No. 9In vitro antitumor immune response induced by dendritic cells transduced with human livin α recombinant adenovirusCellular Immunology, Vol. 297, No. 1Persistence of hAQP1 expression in human salivary gland cells following AdhAQP1 transduction is associated with a lack of methylation of hCMV promoter16 July 2015 | Gene Therapy, Vol. 22, No. 9Efficient Gene Transduction of Dispersed Islet Cells in Culture Using Fiber-Modified Adenoviral Vectors1 August 2015 | Cell Medicine, Vol. 8, No. 1-2Preferable sites and orientations of transgene inserted in the adenovirus vector genome: The E3 site may be unfavorable for transgene position15 January 2015 | Gene Therapy, Vol. 22, No. 5Hybrid Nonviral/Viral Vector Systems for Improved piggyBac DNA Transposon In Vivo DeliveryMolecular Therapy, Vol. 23, No. 4Recombinant adenovirus infection suppresses hTERT expression through virus-associated RNA-mediated induction of type 1 interferonBiochemical and Biophysical Research Communications, Vol. 458, No. 4Arthritis Gene TherapyEstablishment and validation of new complementing cells for production of E1-deleted adenovirus vectors in serum-free suspension cultureJournal of Virological Methods, Vol. 208Adenovirus-Based Vectors: Maximizing Opportunities and Optimizing a Rich Diversity of Vectors for Gene-Based Therapy Andrew H. Baker22 April 2014 | Human Gene Therapy, Vol. 25, No. 4 Volume 25Issue 1Jan 2014 InformationCopyright 2014, Mary Ann Liebert, Inc.To cite this article:Ronald G. Crystal.Adenovirus: The First Effective In Vivo Gene Delivery Vector.Human Gene Therapy.Jan 2014.3-11.http://doi.org/10.1089/hum.2013.2527Published in Volume: 25 Issue 1: January 20, 2014PDF download

Referência(s)